Similarly, M1 (CD68) and M2 (C-MYC) macrophage markers were minimally expressed in FTC/PTC but increased in PDTC and ATC, in line with ST-inferred enrichment of immunosuppressive myeloid populations. The gene discussed is CD68; the disease is thyroid cancer, nonmedullary, 2.